Direxion Daily S&P Biotech Bull 3X ETF
LABU
47 hedge funds and large institutions have $43.4M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 15 closing their positions.
125% more call options, than puts
Call options by funds: $37M | Put options by funds: $16.4M
26% more capital invested
Capital invested by funds: $34.5M → $43.4M (+$8.99M)
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
0% more funds holding
Funds holding: 47 → 47 (0)
0% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 15
0.01% less ownership
Funds ownership: 0.17% → 0.16% (-0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$7.86M |
| 2 |
SW
SVB Wealth
Boston,
Massachusetts
|
+$4.73M |
| 3 |
AIP
Ahrens Investment Partners
Lafayette,
Louisiana
|
+$1.74M |
| 4 |
Belvedere Trading
Chicago,
Illinois
|
+$894K |
| 5 |
IMC Chicago
Chicago,
Illinois
|
+$894K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$2.74M |
| 2 |
LJAC
L.J. Altfest & Co
New York
|
-$1.38M |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$1.14M |
| 4 |
Millennium Management
New York
|
-$780K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$720K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
JP Morgan Chase
New York
| – | -$414K | -3,072 | Closed |
|
|
1WM
52
1900 Wealth Management
San Antonio,
Texas
| – | -$270K | -2,000 | Closed |
|
|
LAM
53
LifePro Asset Management
San Diego,
California
| – | -$242K | -1,799 | Closed |
|
|
PAWC
54
P.A.W. Capital
Greenwich,
Connecticut
| – | -$202K | -1,500 | Closed |
|
|
IA
55
Integrity Advisory
Overland Park,
Kansas
| – | -$169K | -1,250 | Closed |
|
|
HJMC
56
Hellman Jordan Management Company
Quincy,
Massachusetts
| – | -$135K | -1,000 | Closed |
|
57
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$170K | -929 | Closed |
|
58
Goldman Sachs
New York
| – | -$74K | -550 | Closed |
|
59
Barclays
London,
United Kingdom
| – | -$9K | -65 | Closed |
|
|
TCM
60
Tradewinds Capital Management
Bellingham,
Washington
| – | -$4K | -26 | Closed |
|
|
HWMA
61
Heritage Wealth Management (Arizona)
Phoenix,
Arizona
| – | -$1.96K | -15 | Closed |
|
|
HS
62
Horan Securities
Cincinnati,
United States
| – | -$183 | -1 | -50% |
|
LABU Hedge Fund Activity: Q3 2022 in Review
47 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q3 2022, worth a combined $43.4M — up 26% from $34.5M a quarter earlier.
Fund positioning in LABU was balanced in Q3 2022: 15 funds opened new positions, 15 closed out, 11 added to existing stakes and 10 trimmed.
The largest buyer was First Light Asset Management, opening a new position worth an estimated $7.86M. The largest seller was HRT Financial, exiting entirely with an estimated $2.74M sold.
- 47 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $43.4M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q3 2022, up 26% quarter-over-quarter.
- 15 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q3 2022 and 15 closed out, a net change of 0 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q3 2022 was First Light Asset Management, an estimated $7.86M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q3 2022 was HRT Financial, an estimated $2.74M sold.
Based on aggregated 13F filings for Q3 2022.